Uracil in DNA: Consequences for carcinogenesis and chemotherapy

Biochemical Pharmacology

Volumn 76, Issue 6, 2008, Pages 697-706

  Berger, Sondra H ^a   Pittman, Douglas L ^a   Wyatt, Michael D ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Base excision repair; Folate deficiency; Homologous recombination; Thymidylate deprivation

Indexed keywords

CAPECITABINE; DEOXYURIDINE PHOSPHATE; DNA; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLIC ACID ANTAGONIST; METHOTREXATE; METHYLENETETRAHYDROFOLIC ACID; PEMETREXED; RALTITREXED; THYMIDINE PHOSPHATE; URACIL; URACIL DNA GLYCOSIDASE;

ARTICLE; CARCINOGENESIS; CHEMOTHERAPY; CORRELATION ANALYSIS; DNA DAMAGE; DNA STRAND BREAKAGE; DNA SYNTHESIS; EXCISION REPAIR; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 50549086678     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.05.019     Document Type: Note

References (78)

1. Powers H.J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 135 (2005) 2960S-2966S
2. Costi M.P., Ferrari S., Venturelli A., Calo S., Tondi D., and Barlocco D. Thymidylate synthase structure, function and implication in drug discovery. Curr Med Chem 12 (2005) 2241-2258
3. Parker W.B., and Cheng Y.C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48 (1990) 381-395
4. Ahmad S.I., Kirk S.H., and Eisenstark A. Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Ann Rev Microbiol 52 (1998) 591-625
5. Eriksson S., Arner E., Spasokoukotskaja T., Wang L., Karlsson A., Brosjo O., et al. Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy. Adv Enzyme Regul 34 (1994) 13-25
6. Basten G.P., Duthie S.J., Pirie L., Vaughan N., Hill M.H., and Powers H.J. Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 94 (2006) 1942-1947
7. Kim Y.I., Shirwadkar S., Choi S.W., Puchyr M., Wang Y., and Mason J.B. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology 119 (2000) 151-161
8. Crott J.W., Liu Z., Choi S.W., and Mason J.B. Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5-8 of the gene. Mutat Res 626 (2007) 171-179
9. Knock E., Deng L., Wu Q., Leclerc D., Wang X.L., and Rozen R. Low dietary folate initiates intestinal tumors in mice, with altered expression of G2-M checkpoint regulators polo-like kinase 1 and cell division cycle 25c. Cancer Res 66 (2006) 10349-10356
10. Friso S., and Choi S.W. Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6 (2005) 37-46
11. Berger S.H., and Hakala M.T. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil. Mol Pharmacol 25 (1984) 303-309
12. Jackson R.C. The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine, and 3-deazauridine. J Biol Chem 253 (1978) 7440-7446
13. Ladner R.D. The role of dUTPase and uracil-DNA repair in cancer chemotherapy. Curr Protein Pept Sci 2 (2001) 361-370
14. Tye B.K., and Lehman I.R. Excision repair of uracil incorporated in DNA as a result of a defect in dUTPase. J Mol Biol 117 (1977) 293-306
15. Ingraham H.A., Dickey L., and Goulian M. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. Biochemistry 25 (1986) 3225-3230
16. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Ayusawa D., et al. Deoxyribonucleoside triphosphate imbalance 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262 (1987) 8235-8241
17. Ayusawa D., Arai H., Wataya Y., and Seno T. A specialized form of chromosomal DNA degradation induced by thymidylate stress in mouse FM3A cells. Mutat Res 200 (1988) 221-230
18. Canman C.E., Tang H.Y., Normolle D.P., Lawrence T.S., and Maybaum J. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc Natl Acad Sci USA 89 (1992) 10474-10478
19. Li L., Connor E.E., Berger S.H., and Wyatt M.D. Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency. Biochem Pharmacol 70 (2005) 1458-1468
20. Houghton J.A., Tillman D.M., and Harwood F.G. Ratio of 2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin Cancer Res 1 (1995) 723-730
21. Matsui S.I., Arredondo M.A., Wrzosek C., and Rustum Y.M. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res 56 (1996) 4715-4723
22. Canman C.E., Lawrence T.S., Shewach D.S., Tang H.Y., and Maybaum J. Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate. Cancer Res 53 (1993) 5219-5224
23. Canman C.E., Radany E.H., Parsels L.A., Davis M.A., Lawrence T.S., and Maybaum J. Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase. Cancer Res 54 (1994) 2296-2298
24. Koehler S.E., and Ladner R.D. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. Mol Pharmacol 66 (2004) 620-626
25. Webley S.D., Welsh S.J., Jackman A.L., and Aherne G.W. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Br J Cancer 85 (2001) 446-452
26. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., and Ellenberger T. DNA repair and mutagenesis (2006), ASM Press, Washington, D.C.
27. Krokan H.E., Drablos F., and Slupphaug G. Uracil in DNA-occurrence, consequences and repair. Oncogene 21 (2002) 8935-8948
28. Nilsen H., Rosewell I., Robins P., Skjelbred C.F., Andersen S., Slupphaug G., et al. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol Cell 5 (2000) 1059-1065
29. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., et al. Post-replicative base excision repair in replication foci. EMBO J 18 (1999) 3834-3844
30. Nilsen H., Stamp G., Andersen S., Hrivnak G., Krokan H.E., Lindahl T., et al. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22 (2003) 5381-5386
31. Hendrich B., Hardeland U., Ng H.H., Jiricny J., and Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401 (1999) 301-304
32. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297 (2002) 403-405
33. Wong E., Yang K., Kuraguchi M., Werling U., Avdievich E., Fan K., et al. Mbd4 inactivation increases C to T transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci USA 99 (2002) 14937-14942
34. Bader S., Walker M., Hendrich B., Bird A., Bird C., Hooper M., et al. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18 (1999) 8044-8047
35. Riccio A., Aaltonen L.A., Godwin A.K., Loukola A., Percesepe A., Salovaara R., et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23 (1999) 266-268
36. Cortazar D., Kunz C., Saito Y., Steinacher R., and Schar P. The enigmatic thymine DNA glycosylase. DNA Repair (Amst) 6 (2007) 489-504
37. Wyatt M.D., and Pittman D.L. Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem Res Toxicol 19 (2006) 1580-1594
38. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94 (1997) 3290-3295
39. Mashiyama S.T., Courtemanche C., Elson-Schwab I., Crott J., Lee B.L., Ong C.N., et al. Uracil in DNA, determined by an improved assay, is increased when deoxynucleosides are added to folate-deficient cultured human lymphocytes. Anal Biochem 330 (2004) 58-69
40. Duthie S.J., and Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. Faseb J 12 (1998) 1491-1497
41. Duthie S.J., Narayanan S., Blum S., Pirie L., and Brand G.M. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr Cancer 37 (2000) 245-251
42. An Q., Robins P., Lindahl T., and Barnes D.E. 5-Fluorouracil incorporated into DNA is excised by the smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res 67 (2007) 940-945
43. Fischer J.A., Muller-Weeks S., and Caradonna S.J. Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase. Cancer Res 66 (2006) 8829-8837
44. Cortellino S., Turner D., Masciullo V., Schepis F., Albino D., Daniel R., et al. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci USA 100 (2003) 15071-15076
45. Fischer F., Baerenfaller K., and Jiricny J. 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems. Gastroenterology 133 (2007) 1858-1868
46. Meyers M., Wagner M.W., Mazurek A., Schmutte C., Fishel R., and Boothman D.A. DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 280 (2005) 5516-5526
47. Parsels L.A., Parsels J.D., Wagner L.M., Loney T.L., Radany E.H., and Maybaum J. Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells. Cancer Chemother Pharmacol 42 (1998) 357-362
48. Webley S.D., Hardcastle A., Ladner R.D., Jackman A.L., and Aherne G.W. Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331. Br J Cancer 83 (2000) 792-799
49. Andersen S., Heine T., Sneve R., König I., Krokan H.E., Epe B., et al. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. Carcinogenesis 26 (2005) 547-555
50. Li L., Berger S.H., and Wyatt M.D. Involvement of base excision repair in response to therapy targeted at thymidylate synthase. Mol Cancer Ther 3 (2004) 747-753
51. Luo Y., Walla M., and Wyatt M.D. Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase. DNA Repair 8 (2008) 162-169
52. Welsh S.J., Hobbs S., and Aherne G.W. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition. Eur J Cancer 39 (2003) 378-387
53. Cabelof D.C., Raffoul J.J., Nakamura J., Kapoor D., Abdalla H., and Heydari A.R. Imbalanced base excision repair in response to folate deficiency is accelerated by polymerase beta haploinsufficiency. J Biol Chem 279 (2004) 36504-36513
54. Dornfeld K., and Johnson M. AP endonuclease deficiency results in extreme sensitivity to thymidine deprivation. Nucleic Acids Res 33 (2005) 6644-6653
55. Seiple L., Jaruga P., Dizdaroglu M., and Stivers J.T. Linking uracil base excision repair and 5-fluorouracil toxicity in yeast. Nucleic Acids Res 34 (2006) 140-151
56. Tinkelenberg B.A., Hansbury M.J., and Ladner R.D. dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae. Cancer Res 62 (2002) 4909-4915
57. el-Hajj H.H., Wang L., and Weiss B. Multiple mutant of Escherichia coli synthesizing virtually thymineless DNA during limited growth. J Bacteriol 174 (1992) 4450-4456
58. Gadsden M.H., McIntosh E.M., Game J.C., Wilson P.J., and Haynes R.H. dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae. Embo J 12 (1993) 4425-4431
59. Parsels L.A., Parsels J.D., Tai D.C., Coughlin D.J., and Maybaum J. 5-Fluoro-2′-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells. Cancer Res 64 (2004) 6588-6594
60. Robinson H.M., Jones R., Walker M., Zachos G., Brown R., Cassidy J., et al. Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil. Oncogene 25 (2006) 5359-5369
61. Xiao Z., Xue J., Sowin T.J., and Zhang H. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Mol Cancer Ther 5 (2006) 1935-1943
62. Banerjee A., and Benedict W.F. Production of sister chromatid exchanges by various cancer chemotherapeutic agents. Cancer Res 39 (1979) 797-799
63. Ayusawa D., Koyama H., Shimizu K., Kaneda S., Takeishi K., and Seno T. Induction, by thymidylate stress, of genetic recombination as evidenced by deletion of a transferred genetic marker in mouse FM3A cells. Mol Cell Biol 6 (1986) 3463-3469
64. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
65. Symington L.S. Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair. Microbiol Mol Biol Rev 66 (2002) 630-670 table of contents
66. Nakayama K., Kusano K., Irino N., and Nakayama H. Thymine starvation-induced structural-changes in Escherichia-coli DNA-detection by pulsed-field gel-electrophoresis and evidence for involvement of homologous recombination. J Mol Biol 243 (1994) 611-620
67. Kunz B.A., and Haynes R.H. DNA repair and the genetic effects of thymidylate stress in yeast. Mutat Res 93 (1982) 353-375
68. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90 (1997) 425-435
69. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386 (1997) 804-810
70. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
71. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
72. Olson E., Nievera C.J., Lee A.Y., Chen L., and Wu X. The Mre11-Rad50-Nbs1 complex acts both upstream and downstream of ataxia telangiectasia mutated and Rad3-related protein (ATR) to regulate the S-phase checkpoint following UV treatment. J Biol Chem 282 (2007) 22939-22952
73. Thorslund T., and West S.C. BRCA2: a universal recombinase regulator. Oncogene 26 (2007) 7720-7730
74. Tse A.N., Carvajal R., and Schwartz G.K. Targeting checkpoint kinase 1 in cancer therapeutics. Clin Cancer Res 13 (2007) 1955-1960
75. Sorensen C.S., Hansen L.T., Dziegielewski J., Syljuasen R.G., Lundin C., Bartek J., et al. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 7 (2005) 195-201
76. Syljuasen R.G., Sorensen C.S., Hansen L.T., Fugger K., Lundin C., Johansson F., et al. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 25 (2005) 3553-3562
77. Hsueh C.T., Kelsen D., and Schwartz G.K. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. Clin Cancer Res 4 (1998) 2201-2206
78. Wilsker D., and Bunz F. Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival. Mol Cancer Ther 6 (2007) 1406-1413